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Objectives: Vascular endothelial growth factor (VEGF) is reported to be a potent and specific mitogen for endothelial 
cells (EC) and an inducer of angiogenesis in vivo. Originally called vascular permeability factor (VPF), VEGF also 
increases permeability ofmicrovessels to circulating macromolecules. The aim of this study was to examine whether the 
VEGF gene was expressed in porcine arteries following denudation ofEC. 
Design: Experimental nimal model with mechanical injury to large arteries. 
Methods: The right iliac artery of juvenile pigs was de-endothelialised using an inflated balloon catheter. At a number 
of time-points after injury, these arteries were harvested together with uninjured contralateral rteries. Sections of arteries 
were used for RNA analysis by Northern blots and for protein localisation studies by immunohistochemistry. 
Results: Two VEGF transcripts (2.0 kb, 4.5 kb) were markedly elevated inpig arteries oon after injury. Newly synthesised 
VEGF protein was located in smooth muscle cells (SMC) throughout the media of injured arteries. 
Conclusions: The elevated expression ofVEGF by SMC in denuded porcine arteries is evidence that this cytokine plays 
a role in the injury response oflarge arteries. Since several biological ctivities have been identified for VEGF, the function 
of this cytokine in the arterial repair process remains to be determined. 
Keywords: Pig arteries; Balloon injury; Gene expression; Vascular endothelial growth factor; Smooth muscle cells. 
Introduction 
Angioplasty and other forms of surgical intervention 
for occlusive arterial disease are followed by a repair 
process which can lead to restenosis in many patients. 
The arterial injury response is difficult to study in 
humans and nearly all of our knowledge of intimal 
hyperplasia rests on studies carried out on laboratory 
animals. 1 The most common experimental injury is 
induced using an inflated balloon embolectomy cath- 
eter to remove the endothelial layer from a major 
artery. The resultant lesion contains primarily smooth 
muscle cells (SMC) resulting from synchronous pro- 
liferation of SMC in the media beginning at 24 h, 1'2 
and followed by migration of SMC to the luminal 
surface to form a neointima several days later. 3 Over 
the next few weeks, the accumulation of extracellular 
matrix proteins also contributes to the increased vol- 
ume of the arterial intima. 2In animals, the size of the 
lesion is generally self-limiting and it appears that 
* Please address all correspondence to: S. Wysocki, University De- 
partment of Surgery, Fremantle Hospital, PO Box 480, Fremantle, 
Western Australia 6160. 
regeneration of an impervious, non-thrombogenic 
endothelium or pseudoendothel ium 4 results in ces- 
sation of processes leading to intimal hyperplasia. 5'6 
The unique properties of vascular endothelial 
growth factor (VEGF) have focussed attention on this 
cytokine as a potential agent whose administration 
could accelerate re-endothelialisation a d therefore 
enhance remodell ing of injured arteries and diminish 
the extent of intimal hyperplasia. 7 VEGF is a secreted 
glycoprotein believed to be a multifunctional regulator 
of endothelial cell (EC) growth 8whose biological ac- 
tivities are mediated via receptors which are expressed 
predominantly, if not exclusively, on vascular endo- 
thelial cells. 9 In addition to its reported abilities to 
stimulate EC division in vitro and angiogenesis in 
vivo, VEGF was originally called vascular permeability 
factor because it increased microvascular permeability 
to circulating macromolecules. 9 Attempts to use VEGF 
as a therapeutic agent to hasten re-endothelialisation 
of injured arteries have led to contested findings. 
Several groups have reported that administration of 
VEGF to rats and rabbits with balloon-injured arteries 
accelerated EC growth in these vessels. 7'1° By contrast, 
other researchers were unable to demonstrate any 
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stimulation of re-endothelialisation in denuded rat 
arteries using a number of doses of VEGF and various 
treatment protocols. ~IIn this most recent study, the 
authors could not detect VEGF mRNA in injured 
arteries, ~casting some doubt on any function for this 
cytokine in the repair of large arteries; however, there 
may have been problems with sufficient cross hy- 
bridisation of mouse VEGF antisense probes used in 
this investigation. 
In the present study we have examined arterial 
VEGF expression in the pig, an animal model where 
restenosis after angioplasty appears to be more closely 
related to findings obtained for humans, n
Methods 
Animals 
This study used male juvenile (9-11 weeks) domestic 
cross-bred pigs (Landrace and Large White) weighing 
about 20 kg. All pigs were fed normal chow and were 
treated in accordance with the National Health and 
Medical Research Council guidelines for animal re- 
search. A total of 10 pigs were included in this in- 
vestigation. 
Balloon catheter injury to iliac arteries 
Under general anaesthesia, the right iliac was denuded 
of endothelial cells using an inflated 5-French Fogarty 
embolectomy catheter (Baxter). Following an ar- 
teriotomy in the right profunda femoris artery, the 
catheter was passed up to the aortic bifurcation and 
inflated. 13 The inflated balloon catheter was pulled 
down the iliac artery over a 20 s period and this 
procedure was repeated two more times. A consistent 
removal of the endothelium by this injury was dem- 
onstrated in an earlier study. 2The left iliac artery was 
uninjured. 
Harvesting of arteries 
Arteries were harvested at 2 h, 6 h, 8 h, 16 h and 24 h 
after balloon injury. Pigs were given a general 
anaesthetic and underwent a laparotomy. Isotonic sa- 
line was perfused into the infra-renal aorta and 
through distal arteries to drain by the inferior vena 
cava. The right and left common iliac arteries were 
then harvested. Following the surgical removal of 
adventitia (later verified by histology), the arteries 
were dissected into two smaller pieces using transverse 
cuts. Part of the specimen was used for mRNA analysis 
and was frozen in liquid nitrogen before storage at 
-85  °C. The remainder was used for detection of 
VEGF protein using immunohistochemistry and was 
gradually frozen in OCT medium by gradual sub- 
mersion in liquid nitrogen. These preparations were 
also stored at -85  °C prior to sectioning. 
Northern blot analysis 
Frozen arteries were ground to a fine consistency 
under liquid nitrogen using a mortar and pestle and 
the resultant powder was homogenised in Ultraspec 
reagent (Biotecx Laboratories, Houston, TX) by four 
high speed bursts (15 s) using a Janke and Kunkle 
tissue disintegrator (Ultra-Turrax T25). Total RNA was 
then prepared using the Biotecx isolation protocol. 
Aliquots of total RNA were run on formaldehyde gels 
prior to overnight capillary transfer to Hybond N + 
nylon membrane (Amersham, U.K.) and alkali fixa- 
tion. 2 Membranes were hybridised overnight (42 °C) 
to 32P-labelled DNA probes in a hybridisation solution 
containing 50% formamide (Amersham Hybond N + 
protocol). The VEGF probe was labelled by random 
primer extension of the insert and the 36B4 plasmid 
was labelled by nick translation, both using kit pro- 
tocols (Amersham, U.K.). 
DNA probes 
The DNA probes used were as follows: VEGF, a 583 bp 
BamH1/EcoR1 fragment of pVEGF18 and the plasmid 
36B4 originally called pN1.14 36B4 is the cDNA for 
human acidic ribosomal phosphoprotein PO 15 and rep- 
resents an ubiquitously expressed mRNA. 16 
Immunohistochemistry 
Frozen arterial sections (10 ~tm thick) were air-dried 
and fixed in cold acetone for 2 min. Slides were then 
rinsed five times in 0.2 M Tris-buffered saline (TBS) 
for 2 rain before blocking of endogenous peroxidase 
by a 20 rain incubation at room temperature with horse 
serum (20%). Incubation with a 1 in 4 dilution (25 ~tg/ 
ml) of a rabbit polyclonal antibody raised against a 
human VEGF fusion protein construct (sc-507, Santa 
Cruz Biotechnology) was carried out at 4 °C overnight. 
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This pr imary antibody to VEGF was omitted for sec- 
tions serving as negative controls. Slides were washed 
twice in TBS for 5 rain and incubated for 30 rain at 37 °C 
with a 1 in 200 dilution of fluorescein isothiocyanate- 
conjugated swine anti-rabbit immunoglobul in (Dako). 
Following five rinses in TBS for 2 min, slides were 
mounted in glycerol. In separate cell identification 
studies, frozen arterial sections were also incubated 
with mouse anti-human alpha-smooth muscle actin 
(Sigma) as the primary antibody (data not shown). 
Assessment offluorescence staining by confocaI laser 
scanning microscopy (CLSM) 
The detection of fluorescence staining in arterial sec- 
tions was performed using a Bio-Rad CLSM (MRC- 
1000 UV) equipped with a 250 mW argon ion laser 
coupled to an epifluorescence Nikon Diaphot 300 in- 
verted microscope. A 20X glycerine immersion lens 
(Nikon UV-F20, NA=0.8) was employed. The ex- 
citation wavelength was 488 nm attenuated to3%, and 
an emission band pass filter (522/35 bp) was utilised. 
Serial optical sections were taken at 2 gm intervals and 
the images presented are maximal projections. 
Results 
Expression of the VEGF gene in pig arteries following 
balloon injury 
To determine whether VEGF is expressed during repair 
of arteries, as it is in other regenerating tissues, we 
carried out Northern blot analysis of total RNA ex- 
tracted from injured pig arteries using a 32p-labelled 
human cDNA probe. We observed that two VEGF 
mRNAs were clearly identifiable in pig iliac arteries, 
the larger VEGF transcript being estimated to be about 
4.5 kb and the second, much smaller transcript at about 
2.0 kb (Fig. 1). Similar sized VEGF transcripts have 
been previously detected in human tissues and tissues 
and cultured cells from the guinea pig, including 
SMC.  ~7 Additional VEGF mRNAs of 5.5 kb and 3.7 kb, 
which had been demonstrated in human foetal vas- 
cular SMC, 18 were not obvious in pig arteries. 
The transient expression of VEGF during de- 
velopment and repair has been interpreted as evidence 
of a role for this cytokine in the regulation of endo- 
thelial cell growth. Accordingly, we examined the time 
course of VEGF gene expression during early arterial 
repair in the pig. The VEGF transcripts were just 
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Fig. 1. Expression of the VEGF gene in pig iliac arteries after a 
balloon catheter injury. Total RNA was extracted from right iliac 
arteries at specified times after injury and also from the uninjured 
contralateral arteries. Aliquots were subjected to Northern blot 
analysis using 32p-labelled cDNA probes. 36B4 mRNA is ubi- 
quitously expressed and has been used as an internal control t  
reflect the evenness of loading. Note that the VEGF transcripts were 
just detectable in uninjured arteries and were rapidly elevated in 
injured arteries at 2 h before reaching maximal levels at 6-8 h after 
balloon injury. The mRNA in lane 9 (8 h) was partially degraded 
so that the 4.5 kb transcript was not obvious; however the 2.0 kb 
transcript was clearly elevated. 
detectable in uninjured arteries and were rapidly el- 
evated at 2 h in injured arteries before reaching max- 
imal levels at 6-8 h after balloon injury (Fig. 1). This 
elevation was not due to a generalised increase in 
mRNAs as the level of the reference 36B4 mRNA 
remained fairly constant hroughout early arterial re- 
pair. By 16-24 h after balloon injury, the levels of VEGF 
mRNAs were much reduced, although transcript levels 
were still slightly higher than observed in uninjured 
arteries (Fig. 1). 
Localisation of VEGF protein in injured pig arteries 
Immunohistochemistry was utilised to determine the 
cellular origin of VEGF expression in frozen sections 
from pig arteries employing a rabbit polyclonal anti- 
body to human VEGF which recognises the 165, 189 
and 121 amino acid splice variants of this cytokine. 
Strong immunoreactivity for VEGF was demonstrated 
throughout the inner two thirds of the media of pig 
iliac artery at 6 h after injury (Fig. 2b). Staining was 
uniform throughout his part of the media and the 
distribution was identical to that obtained with alpha- 
smooth muscle actin (not shown) indicating that SMC 
were the predominant source of the immunoreactivity. 
Macrophages are located in pig arteries at 6 h after 
balloon injury 12 but any potential contribution from 
these immune cells would have been masked by the 
overwhelmingly more numerous SMC. VEGF im- 
munoreactivity in the outer one third of the media of 
injured arteries was scattered and not as intense (Fig. 
2b), and there was a minimal VEGF reactivity in the 
media of uninjured artery (Fig. 2a). 
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Fig. 2. Detection of VEGF protein-positive cells in pig iliac arteries 6h after balloon injury. Frozen sections of artery were processed by 
standard immunohistochemical methodology using a polyclonal antibody to human VEGF and a FITC-labelled secondary antibody. 
Detection of fluorescein staining was performed by confocal laser scanning microscopy. Sections w re c unter-stained with haematoxylin. 
(A) VEGF protein immunostaining of a transverse section of uninjured artery. (B) VEGF protein immunostaining of a transverse section 
of injured artery collected at 6 h after balloon injury. (C) Immunostaining of an adjacent serial section of i jured artery in the absence of 
primary antibody. For all sections the arterial lumen is in the top right and co ner. The size bar is 100 #m. Note the presence of VEGF 
protein-staining cells throughout the inner two thirds of the media in iliac artery t 6 h after injury (B). Cells within this part of the artery 
stained strongly positive for alpha~smooth muscle actin (~SMA) (not shown). 
Discussion 
Current understanding of arterial intimal hyperplasia 
is based largely on experimental investigations using 
small laboratory animals. Fishman and colleagues de- 
veloped a model in which clearly delineated endo- 
thelial denudation was achieved by brief air-drying of 
the lumen of rat carotid artery. ~ These researchers 
established that endothelial regeneration resulted from 
regrowth of EC from each end of the denuded segment 
and that the duration of endothelial denudation cor- 
related with degree of intimal thickening, s This latter 
observation supports the hypothesis that a functional 
endothelial layer is required to dampen down arterial 
intimal hyperplasia following surgery and has promp-  
ted investigations into whether application of the EC 
mitogen VEGF could stimulate re-endothelialisation 
in denuded arteries and thereby eventually ttenuate 
intimal thickening. 
Two recent studies reported ata suggesting that this 
strategy would be successful. Callow and colleagues 
demonstrated accelerated endothelial regrowth in ca- 
rotid arteries from rabbits which had received intra- 
venous infusion of vascular permeabil ity factor (VPF/ 
VEGF) compared to controls receiving vehicle. 1° Ash- 
ara and co-workers reported similar enhanced re- 
endothelialisation of rat carotid arteries which had 
been incubated with VEGF in situ and, significantly, 
there was also a reduction in intimal thickening in 
these arteries. 7 By contrast, Lindner and Reidy were 
unable to show much stimulation of endothelial re- 
growth in carotid arteries from rats receiving an in- 
fusion of VEGF. 11 These authors reported that denuded 
rat carotid arteries did not express VEGF message, a
finding which appeared to explain their observation 
of a lack of function for VEGF in arterial re-endo- 
thelialisation. 
In the present study we were able to demonstrate 
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that VEGF gene expression was detectable in pig iliac 
arteries and that it was rapidly elevated following a 
balloon injury, suggesting that this multifunctional 
cytokine does play a role in arterial repair in the 
pig. Transient VEGF expression has been previously 
observed in several models of wound repair in other 
tissues including liver 19 and skin, 2° and also in a model 
of pressure-induced ventricular hypertrophy. 21 We feel 
confident hat we were in fact detecting VEGF tran- 
scripts because we used stringent washing conditions 
in our hybridisation protocol and the sizes of the 
transcripts detected were identical to those reported 
for tissues and cell lines by other researchers) 7 When 
studying cytokine gene expression we routinely run 
as a positive control total RNA extracted from cells 
cultured from a human giant cell tumour of bone. 
These cells strongly express a number of cytokines 
including transforming rowth factor-[~122 and VEGF 
(Zheng et al., unpublished observations). We cannot 
explain why Lindner and Reidy were not able to detect 
VEGF gene expression in denuded rodent vessels and 
it is unclear whether these authors used a positive 
control in their investigations. ~1 It is possible that there 
is a species difference in expression of VEGF during 
arterial repair. 
In our investigation we have provided evidence that 
VEGF protein was located in SMC throughout he 
media of injured pig arteries. Similar findings have 
been reported for human myometrium where VEGF 
mRNA and VEGF protein were uniformly distributed 
in SMC, also the predominant cell type in this tissue. 23 
In both studies the spatial distribution of VEGF ex- 
pression did not clearly coincide with areas of rapidly 
proliferating endothelial cells, unlike the localisation 
of the VEGF receptor, fit-l, which was rapidly up- 
regulated at the leading edge of regenerating endo- 
thelium in injured rat arteries. 1~ The human gene for 
VEGF is split among eight exons and various tran- 
scripts arise from alternative splicing) s Three VEGF 
transcripts corresponding to VEGF189, VEGF165 and 
VEGF12~ have been detected in human uterine tissues 24 
but the techniques used in our study of pig arteries 
do not recognise splice variants. 
In previous studies we have reported orchestrated 
changes in cytokine gene expressions in pig arteries 
following balloon injury including TGF-[31 and MCP- 
12'12 and we can now add VEGF to the list of cytokines 
whose expression isupregulated during arterial repair. 
In doing so we have further characterised molecular 
events in a useful animal model which has similarities 
to human arterial intimal hyperplasia. VEGF is a multi- 
functional-cytokine which acts as a specific regulator 
of endothelial cell growth s and also increases micro- 
vascular permeability to circulating macromolecules. 9 
Two high affinity receptors for VEGF, fit-l, and ilk- 
1, are localised to vascular endothelium 24'25 and are 
believed to mediate the effects of VEGF on the vas- 
culature. 9 A recent study has reported that VEGF 
binding toflk-1 ellicited EC proliferation whereas bind- 
ing to fit-1 did not. 26 Bearing in mind that fit-1 ex- 
pression was upregulated at the leading edge of 
regenerating endothelium in injured rat arteries, the 
biological function of the increased VEGF expression 
in injured pig arteries observed by us remains unclear. 
Experimentally, the loss of the endothelial layer in 
large arteries causes triking intimal hyperplasia 5 and 
may impair remodelling. Inadequate re-endo- 
thelialisation may also contribute to restenosis fol- 
lowing angioplasty. 1° It was hoped therefore that 
acceleration of re-endothelialisation by administration 
of a specific mitogen such as VEGF would diminish 
the degree of arterial intimal hyperplasia. This ex- 
perimental approach would not appear valid if this 
cytokine does not normally play a role in arterial 
repair. 1: In the present study we have demonstrated 
that increased VEGF expression was associated with 
the arterial response to balloon injury in pigs, a finding 
which is suggestive of a role for this cytokine in the 
arterial repair process in this species. 
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